RXL.US ProShares Ultra Health Care
- Total assets
- 117M
- Expense ratio
- 0.95%
- Dividend yield
- 0.90%
- 1-year return
- +43.74%
- Holdings
- 61
- Since
- 2007
Fund data as reported by the issuer, updated Nov 17, 2026. Total assets are in the fund's base currency.
What does RXL.US invest in?
- Mostly US stocks (67.6%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (100.0%)
- Top 3 holdings: 29.9% of the fund
Asset allocation
- US stocks 67.6%
- Other 18.7%
- Cash 18.4%
Top holdings
- Proshares Genius Money Market ETF 13.33%
- Eli Lilly and Company 10.40%
- Johnson & Johnson 6.17%
- AbbVie Inc 4.63%
- UnitedHealth Group Incorporated 3.39%
ProShares Ultra Health Care performance
Sharpe ratio 0.71- This year
- +40.87%
- 1 year
- +43.74%
- 3 years
- +22.98%
- 5 years
- +7.88%
Volatility 35.4% over 1 year and 28.4% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
RXL.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About ProShares Ultra Health Care
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Full fund profileProShares Ultra Health Care top holdings
49.4% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Proshares Genius Money Market ETF IQMM.US | - | United States | 13.33% |
| Eli Lilly and Company LLY.US | Healthcare | United States | 10.40% |
| Johnson & Johnson JNJ.US | Healthcare | United States | 6.17% |
| AbbVie Inc ABBV.US | Healthcare | United States | 4.63% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 3.39% |
| Merck & Company Inc MRK.US | Healthcare | United States | 3.30% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 2.40% |
| Amgen Inc AMGN.US | Healthcare | United States | 2.27% |
| Gilead Sciences Inc GILD.US | Healthcare | United States | 1.91% |
| Abbott Laboratories ABT.US | Healthcare | United States | 1.63% |
The 10 largest of 61 holdings.
RXL.US sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
RXL.US regional exposure
- North America100.0%
Share of the stocks in the fund.
Company size
Average market cap 240B- Mega cap10.8%
- Big cap39.5%
- Medium cap12.6%
- Small cap0.9%
ProShares Ultra Health Care fund profile
- Fund name
- ProShares Ultra Health Care
- Ticker
- RXL.US
- Exchange
- USA Stocks
- Issuer
- ProShares
- Fund website
- proshares.com/funds/rxl.html
- Index tracked
- -
- Category
- Leveraged & Inverse Equity
- Domicile
- United States
- Inception date
- Jan 30, 2007
- Trading currency
- USD
- Expense ratio
- 0.95%
- Annual turnover
- 0.2%
About ProShares Ultra Health Care
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of health care companies included in the S&P 500 Index. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.